Brief: XpresSpa Group Receives Approval For For Biosurveillance Tracking In Collaboration With Concentric By Ginkgo At Three Major U.S. Airports

XWELL

13/08/2021 13:32

Aug 13 (Reuters) - XpresSpa Group Inc  XSPA.O :
    * XPRESSPA GROUP™ RECEIVES APPROVAL FOR A $2 MILLION PROGRAM
WITH
THE CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) FOR
BIOSURVEILLANCE TRACKING IN COLLABORATION WITH CONCENTRIC BY
GINKGO AT THREE MAJOR U.S. AIRPORTS
    * XPRESSPA GROUP INC - 8-WEEK PILOT PROGRAM, CONDUCTED IN
COLLABORATION WITH CONCENTRIC BY GINKGO
    * XPRESSPA - XPRESCHECK TO CONDUCT BIOSURVEILLANCE
MONITORING,
INITIALLY FROM INDIA, AT 3 MAJOR U.S. AIRPORTS OPERATING
XPRESCHECK COVID-19 TESTING FACILITIES

Source text for Eikon:  ID:nGNX3zCHJT 
Further company coverage:  XSPA.O 

 ((Reuters.Briefs@thomsonreuters.com;))